(Press-News.org) High-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT), for previously untreated patients with advanced follicular lymphoma (FL) does not improve overall survival compared with conventional-dose chemotherapy alone, according to an online study published December 21 in the Journal of the National Cancer Institute.
Follicular lymphoma is the most common sub-type of non-Hodgkin's lymphoma in North America, characterized by a long natural history, with multiple remissions and relapses following treatment. A number of chemotherapy regimens have been combined with ASCT in randomized clinical trials to treat follicular lymphoma, however, the effects of HDC-ASCT on event-free survival have varied.
In order to determine the impact of HDC-ASCT vs conventional-dose chemotherapy in adult patients with advanced follicular lymphoma, Murtadha Al Khabori in the Division of Medical Oncology and Hematology at Princess Margaret Hospital in Toronto, Ontario, and colleagues performed a systematic review and meta-analysis of randomized control trials comparing chemotherapy alone to chemotherapy with ASCT.
The researchers identified relevant studies dating from 1947-2009 in the literature and publicly available databases to look at overall survival, event-free survival, and any adverse events associated with treatment from either conventional-dose chemotherapy or high dose-chemotherapy with ASCT.
Seven randomized clinical trials (RCTs) met the eligibility criteria. Of these seven, three showed moderate quality evidence that high-dose chemotherapy with ASCT did not improve the overall survival of adult follicular lymphoma patients. The four remaining RTCs highlighted low-quality evidence showing improvement in event-free survival for patients who received chemotherapy with ASCT. The absolute risk of death from treatment and adverse events did not vary between the two treatment groups.
The authors concluded that high-dose chemotherapy combined with ASCT did not improve overall survival in previously untreated adult patients with follicular lymphoma. However, the researchers note certain limitations of the study, namely that, "Trials with no statistically significant treatment effect or those that stopped early because of toxic effects in the ASCT arm are more likely not to be published." They add that data from the unpublished trials should be made available to better assess treatment effects and to develop future clinical trials. "Trials of ASCT in the context of current chemoimmunotherapy approaches in FL are needed to further evaluate the ability of intensification of therapy using ASCT to improve OS," the authors write.
In an accompanying editorial, Caron A. Jacobson and Dan L. Longo, M.D., at the Department of Medicine at Brigham and Women's Hospital in Boston, write that this meta-analysis is timely in light of recent data on the efficacy of maintenance rituximab, which when added to various chemotherapeutic regimens, has improved overall survival. Because of this, along with rituximab's low toxicity profile, Jacobson and Longo conclude, "We recommend rituximab maintenance therapy (in preference to HDC-ASCT) for patients achieving at least a partial response to first-line chemoimmunotherapy in the absence of any randomized controlled trials comparing the two." Furthermore, "HDC-ASCT is a powerful treatment strategy for patients with follicular lymphoma, but one that does not appear to be less effective in the setting of the first disease relapse than in primary treatment, and thus can be reserved for the salvage setting."
###
Contact Info:
Article: Michael Crump, MD, FRCPC Department of Medical Oncology and Hematology, Princess Margaret Hospital, 610 University Avenue, 5-110, Toronto, ON M5G 2M9, Canada
Email: Michael.Crump@uhn.on.ca
Editorial: Caron Jacobson MD Dana-Farber Cancer Institute 450 Brookline Avenue Boston, MA 02215
Email: cajacobson@partners.org
Autologous stem cell transplantation does not improve os in patients with follicular lymphoma
2011-12-22
ELSE PRESS RELEASES FROM THIS DATE:
Gene links rare and unrelated cancers
2011-12-22
Scientists at the BC Cancer Agency, Vancouver Coastal Health Research Institute, and the University of British Columbia are excited over a discovery made while studying rare tumour types.
Dr. David Huntsman, genetic pathologist and director of the Ovarian Cancer Program of BC at the BC Cancer Agency and Vancouver Coastal Health Research Institute and Dr. Gregg Morin, a lead scientist from the Michael Smith Genome Sciences Centre at the BC Cancer Agency, led a team who found mutations in rare, seemingly unrelated cancers were all linked to the same gene, known as DICER.
The ...
Connecticut Gets Smart on Crime With Inmate Early Release Law
2011-12-22
Connecticut Gets Smart on Crime With Inmate Early Release Law
As Connecticut and other states grapple with tight budgets, many have made attempts to lower recidivism, or the rate at which released prisoners are reincarcerated for new crimes. A national study found that more than 40 percent of people released from prison end up back behind bars.
However, a new law in Connecticut may help to rehabilitate inmates and prevent or reduce recidivism. The state's new "risk reduction" credit program allows inmates in Connecticut to earn credits toward an earlier ...
Landmark discovery has magnetic appeal for scientists
2011-12-22
A fundamental problem that has puzzled generations of scientists has finally been solved after more than 70 years.
An international team of scientists has discovered a subtle electronic effect in magnetite – the most magnetic of all naturally occurring minerals – causes a dramatic change to how this material conducts electricity at very low temperatures.
The discovery gives new insight into the mineral in which mankind discovered magnetism, and it may enable magnetite and similar materials to be exploited in new ways.
The research, published in Nature, was led ...
Rare genetic mutations linked to bipolar disorder
2011-12-22
An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, reports that abnormal sequences of DNA known as rare copy number variants, or CNVs, appear to play a significant role in the risk for early onset bipolar disorder.
The findings will be published in the Dec. 22 issue of the journal Neuron.
CNVs are genomic alterations in which there are too few or too many copies of sections of DNA. Researchers have known that spontaneously occurring (de novo) CNVs – genetic mutations not inherited from parents – significantly ...
National Metal Fabricators Recognized By ILG For Their Quality System & Efficiency
2011-12-22
Industrial Leaders, an online network established in 2003 for the manufacturing community, announced today the launch of its latest marketing campaign to help companies in Nevada locate a suitable job shop approved by AMSN at http://www.MFGpartners.net The company said it will combine a number of promotional strategies to help bring work to local machine shops and custom manufacturers throughout the Silver State by connecting local businesses and organizations with the most suitable vendors presented on the IndustrialLeaders.com website.
According to Industrial Leaders, ...
Pathogenic landscape of HIV
2011-12-22
In perhaps the most comprehensive survey of the inner workings of HIV, an international team of scientists led by researchers at the University of California, San Francisco has mapped every apparent physical interaction the virus makes with components of the human cells it infects—work that may reveal new ways to design future HIV/AIDS drugs.
Explored this week in back-to-back papers in the journal Nature, the survey reveals a pathogenic landscape in which HIV's handful of proteins makes hundreds of physical connections with human proteins and other components inside ...
Andalucian International Walking & Cultural Festival 2012
2011-12-22
Frontier Holidays are hosting the Andalucian International Walking & Cultural Festival in co-operation with the Town Hall of El Burgo and the Sierra de las Nieves Nature Park. This event will take place from February 26th to March 4th and promises to be an unforgettable holiday experience.
The white mountain village of El Burgo, close to Sierra de las Nieves Nature Park is the glorious setting for the festival. This area has select status as a member of the EDEN project, recognising areas of outstanding natural beauty and cultural importance across the European continent.
The ...
goFLUENT Rewarded in the United States by Prestigious American Body Brandon Hall
2011-12-22
goFLUENT was delighted to walk away with the "Brandon Hall Bronze Award" for the "Best Use of Blended Learning" category only a few days after being shortlisted, in two categories, for the Learning Awards 2012 in London.
Prestigious awards like these are rarely given to European training providers - and even more so to those in the field of English language training. Receiving this award demonstrates goFLUENT's position as a global leader within the market, believes Christophe Ferrandou, CEO of the goFLUENT group.
This success comes only a few ...
Knowsley Safari Park Continues to Support Zoo Outreach Organisation
2011-12-22
Knowsley Safari Park has supported the Zoo Outreach Organisation for years, contributing financial support and generating awareness of the organisations hard work throughout the world; 2011 was no different, and a massive financial contribution was just one way in which Knowsley Safari Park, one of the UK's best loved animal attractions, has helped ZOO in the past 12 months.
The Zoo Outreach Organisation works with individuals and institutions across the globe to promote conservation education, conservation research, conservation (wildlife) welfare and conservation action. ...
Winning fights increases aggression, even in crickets
2011-12-22
Winning a fight can raise aggressiveness, and a study of fighting crickets, published Dec. 21 in the online journal PLoS ONE, provides new insight into the biochemical mechanism that may be responsible.
The researchers, led by Paul Stevenson of the University of Leipzig in Germany, staged cricket "tournaments" to investigate the source of the heightened aggression, called the "winner effect", and the potential role of different treatments on this effect. They found that the increased aggression associated with the winner effect is transient; the aggression levels returned ...